24 February 2020 - Diagnostic testing is available to identify which patients are most likely to benefit from BALVERSA, offering a ...
24 February 2020 - Perrigo and its partner, Catalent Pharma Solutions, today announced that the U.S. FDA has approved Perrigo's abbreviated ...
25 February 2020 - 17th patient dosed in the ongoing phase 2/3 AAVance study. ...
24 February 2020 - Fixed-dose combination is administered under the skin in just minutes, compared to hours with intravenous administration, significantly ...
25 February 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...
24 February 2020 - Agency supports development of complex generic drugs to improve competition and access to more affordable medicines. ...
25 February 2020 - A transition period is in effect until the end of 2020 while the UK and EU negotiate ...
24 February 2020 - Designed with MF59 adjuvant to help strengthen, broaden and lengthen the body's immune response against the influenza ...
24 February 2020 -- ContraFect today announced that that the U.S. FDA has granted breakthrough therapy designation to exebacase for ...
24 February 2020 - Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically-meaningful outcomes of niraparib ...
25 February 2020 - Prescription Drug User Fee Act target action date set for 23 June 2020. ...
24 February 2020 - Teva’s digital inhaler portfolio now includes products from three of the most commonly prescribed classes of ...
24 February 2020 - Today, the FDA is releasing the first phase of the enhancement of the “Purple Book: Database of ...
24 February 2020 - Real world evidence has the potential to enhance the efficiency of drug development and provide new evidence ...
24 February 2020 - Filings are supported by Phase III ASCLEPIOS I and II studies, where ofatumumab showed highly significant and ...